Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

  • STATUS
    Recruiting
  • participants needed
    1000
  • sponsor
    Groupe Hospitalier Pitie-Salpetriere
Updated on 6 February 2023
azithromycin
lopinavir
lopinavir/ritonavir
covid-19
coronavirus
remdesivir
chloroquine

Summary

The outbreak of Covid-19 started several clinical trials and treatment experiments all over the world in the first months of 2020. This study investigates reports of adverse events related to used molecules, including but not limited to protease inhibitors (lopinavir/ritonavir), chloroquine, azithromycin, remdesivir and interferon beta-1a. Analyses of reports also include the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

Details
Condition Coronavirus, Iatrogenic Disease, Acute Kidney Injury, ARDS, Human
Treatment Any drug used to treat Covid-19
Clinical Study IdentifierNCT04314817
SponsorGroupe Hospitalier Pitie-Salpetriere
Last Modified on6 February 2023

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note